(NASDAQ: NAUT) Nautilus Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 235.73%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.55%.
Nautilus Biotechnology's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast NAUT's revenue for 2025 to be $25,261,024, with the lowest NAUT revenue forecast at $25,261,024, and the highest NAUT revenue forecast at $25,261,024. On average, 1 Wall Street analysts forecast NAUT's revenue for 2026 to be $896,766,366, with the lowest NAUT revenue forecast at $896,766,366, and the highest NAUT revenue forecast at $896,766,366.
In 2027, NAUT is forecast to generate $2,288,396,200 in revenue, with the lowest revenue forecast at $2,288,396,200 and the highest revenue forecast at $2,288,396,200.